microRNA Replacement Therapy
Press Releases

Press Releases
Date Title and Summary View
03-14-17 AUSTIN, Texas--(BUSINESS WIRE)-- Mirna Therapeutics, Inc. (Nasdaq: MIRN), a biopharmaceutical company, today reported financial results for the fourth quarter and year ended December 31, 2016 and provided a corporate update. Following its November 2016 decision to discontinue all research and ...
Page: FirstPrevious ...
= add release to Briefcase
© 2017 Mirna Therapeutics, Inc. All Rights Reserved.